We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-2.03%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.68B
AUM Growth
-$7.95M
Cap. Flow
+$55.2M
Cap. Flow %
3.28%
Top 10 Hldgs %
17.16%
Holding
515
New
107
Increased
139
Reduced
156
Closed
69

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$46.2M
2
RACE icon
Ferrari
RACE
+$26.2M
3
DINO icon
HF Sinclair
DINO
+$10.4M
4
PFE icon
Pfizer
PFE
+$10.1M
5
FTI icon
TechnipFMC
FTI
+$9.95M

Sector Composition

Rank Sector Weight
1 Healthcare 24.95%
2 Technology 20.52%
3 Consumer Discretionary 16.46%
4 Industrials 8.03%
5 Financials 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACIA
501
DELISTED
Acacia Communications Inc
ACIA
-101,200
Closed -$4.77M
AMAG
502
DELISTED
AMAG Pharmaceuticals
AMAG
-96,842
Closed -$967K
ETFC
503
DELISTED
E*Trade Financial Corporation
ETFC
-200,171
Closed -$8.93M
BREW
504
DELISTED
Craft Brew Alliance, Inc.
BREW
-11,000
Closed -$154K
JE
505
DELISTED
Just Energy Group Inc
JE
-1,462
Closed -$208K
CLUB
506
DELISTED
Town Sports International Holdings, Inc.
CLUB
-11,200
Closed -$24K
UCFC
507
DELISTED
United Community Financial Corp
UCFC
-18,815
Closed -$180K
CARB
508
DELISTED
Carbonite Inc
CARB
-39,900
Closed -$1.04M
PSDO
509
DELISTED
Presidio, Inc. Common Stock
PSDO
-40,293
Closed -$551K
VSI
510
DELISTED
Vitamin Shoppe Inc.
VSI
-54,100
Closed -$213K
GHDX
511
DELISTED
Genomic Health, Inc.
GHDX
-59,500
Closed -$3.46M
HIVE
512
DELISTED
Aerohive Networks
HIVE
-81,969
Closed -$363K
PETX
513
DELISTED
Aratana Therapeutics, Inc.
PETX
-26,800
Closed -$138K
ELGX
514
DELISTED
Endologix Inc
ELGX
-33,400
Closed -$242K
VSTO
515
DELISTED
Vista Outdoor Inc.
VSTO
-93,100
Closed -$827K

Similar funds

PDT Partners's Q3 2019 Portfolio in Review

As of Q3 2019, PDT Partners held 515 positions worth $1.68B, down 0.47% from $1.69B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

PDT Partners deployed $55.2M of net new capital in Q3 2019, opening 107 new positions and adding to 139 existing holdings. Its largest new stake was Linde: 238,663 shares worth $46.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $51.3M trimmed.

  • PDT Partners's largest Q3 2019 buy was Linde: 238,663 shares worth $46.2M.
  • PDT Partners added most to Ferrari in Q3 2019, an estimated $26.2M increase.
  • PDT Partners's biggest Q3 2019 reduction was AbbVie, cutting an estimated $51.3M.
  • PDT Partners fully exited Mettler-Toledo International in Q3 2019, selling an estimated $37.2M.
  • PDT Partners's ten largest holdings make up 17% of its $1.68B portfolio in Q3 2019.
  • PDT Partners opened 107 new positions and closed 69 in Q3 2019.
  • PDT Partners's portfolio value fell 0.47% quarter-over-quarter to $1.68B.

Based on PDT Partners's 13F filing for Q3 2019, filed 14 Nov 2019.